个股
共 6,296 份研报 · 国内 4,037 · 国外 1,841
关注风机盈利修复及绿醇产业化进展
华泰证券·2026-10-25·6 页·A股
多重利好叠加致利润同增
华泰证券·2026-10-25·6 页·A股
自主品牌增长强劲,利润仍承压
Shenzhen Crastal Technology (300824 CH): Strong Growth in Own Brands, Profit Still Under Pressure
华泰证券·2026-10-25·8 页·创业板
海南钧达新能源科技:看好三大拐点共振
Hainan Drinda New Energy Tech (002865 CH/2865 HK): Positive on Three Converging Inflection Points
华泰证券·2026-10-25·8 页·A股
订单结构优化支撑风机盈利修复
Sany Renewable Energy (688349 CH): Order Mix Optimization Supports Recovery in Wind Turbine Profitability
华泰证券·2026-10-25·8 页·科创板
新签订单稳健增长,短期毛利率承压
Sinoma International (600970 CH): Order Growth Robust, Margins Under Short-Term Pressure
华泰证券·2026-10-25·7 页·A股
稳健经营与高分红下的投资价值
Dynagreen Env (601330 CH/1330 HK) Investment Value in Stable Operations & High DPS
华泰证券·2026-10-25·7 页·A股
H股股息率2026年有望达到7.8%
TCEPC (600874 CH/1065 HK): H-share Dividend Yield Likely to Reach 7.8% in 2026
华泰证券·2026-10-25·7 页·A股
燃气轮机需求强劲推动合同负债大幅增长
Jereh Oilfield Services (002353 CH): Contract Liabilities Jumped on Strong Gas Turbine Demand
华泰证券·2026-10-25·8 页·A股
BES6100进入客户送样阶段
BES6100 Entering Client Sampling Stage
华泰证券·2026-10-25·8 页·科创板
外加剂销量三季度同比转正
Sobute New Materials (603916 CH): Additives Sales YoY Turned Positive in 3Q26
华泰证券·2026-10-25·8 页·A股
紫金矿业:首次点评:2026年第三季度略低于预期;赤峰黄金收购完成构成积极催化剂
Zijin Mining First Take: 3Q26 slight miss; Chifeng acquisition completion a positive catalyst
摩根大通·2026-10-25·12 页·A股
洛阳钼业A/H股:首次点评:2026年第三季度略低于预期;成本上涨及现金流为关注重点
CMOC A/H: First Take: 3Q26 slight miss; cost inflation and cash flow key to monitor
摩根大通·2026-10-25·11 页·A股
赛峰:为增长投资,但管理层的信息传递令我们措手不及
Safran: Investing for growth, but the messaging caught us off guard
摩根大通·2026-10-25·17 页·其它
强生公司:ESMO会议公布积极数据——瑞他普坦(前列腺癌)与Rybrevant(头颈部癌)
Encouraging Riptac (Prostate) And Rybrevant (H&N) Data Out Of ESMO
摩根大通·2026-10-25·8 页·美股
苹果:产品供应追踪周报第7周:双屏版交付周期持续延长;专业系列交付周期显示需求依然强劲,尽管价格上涨
Apple: Product Availability Tracker Wk7: Extended Duo Lead Times Persist; Pro Lineup Lead Times Suggest Resilient Demand Despite Price Increases
摩根大通·2026-10-25·11 页·美股
利物浦:2026年第三季度前瞻——毛利率改善有助业绩,但同店销售增长放缓、不良贷款率上升及诺德斯特龙估值下调使我们维持低于市场一致预期的判断
Liverpool: 3Q26 Preview — Gross Margin Helps, but Slower SSS, Rising NPLs and a Lower Nordstrom Keeps Us Below Consensus
摩根大通·2026-10-25·16 页·其它
首评:2026年前三季度业绩疲软或成为出清事件;海外订单储备(backlog)成为亮点
First Take: weak 9M26 print can emerge as a clearing event; overseas backlog a silver lining
摩根大通·2026-10-25·10 页·港股
Dr. Reddy's Labs(德里红十字实验室):利润率改善但可持续性为关键,上市风险仍存;评级上调至中性
Dr. Reddy's Labs: Margin delivery improves but sustainability is key, launch risks remain; upgrade to Neutral
摩根大通·2026-10-25·13 页·其它
安进公司:Imdelltra 在一线维持治疗小细胞肺癌中蕴含重要机遇
Amgen Inc (AMGN): Meaningful Imdelltra Oppty In 1L Maintenance SCLC
摩根大通·2026-10-25·8 页·美股
显示 3521 - 3540 条,共 6,296 条